DK2109449T3 - Lægemiddel til behandling af endometriose - Google Patents

Lægemiddel til behandling af endometriose

Info

Publication number
DK2109449T3
DK2109449T3 DK08751001.2T DK08751001T DK2109449T3 DK 2109449 T3 DK2109449 T3 DK 2109449T3 DK 08751001 T DK08751001 T DK 08751001T DK 2109449 T3 DK2109449 T3 DK 2109449T3
Authority
DK
Denmark
Prior art keywords
endometriosis
drug
treatment
Prior art date
Application number
DK08751001.2T
Other languages
Danish (da)
English (en)
Inventor
Antonio Pellicer-Martinez
Carlos Simon-Valles
Edurne Novella-Maestre
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07250429A external-priority patent/EP1952813A1/en
Priority claimed from GB0712626A external-priority patent/GB2450533A/en
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK2109449T3 publication Critical patent/DK2109449T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK08751001.2T 2007-02-01 2008-02-01 Lægemiddel til behandling af endometriose DK2109449T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07250429A EP1952813A1 (en) 2007-02-01 2007-02-01 Medicament for the treatment of endometriosis
US94716507P 2007-06-29 2007-06-29
GB0712626A GB2450533A (en) 2007-06-29 2007-06-29 Treatment and prevention of endometriosis using dopamine agonists.
PCT/IB2008/001273 WO2008093247A2 (en) 2007-02-01 2008-02-01 Medicament for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
DK2109449T3 true DK2109449T3 (da) 2011-09-12

Family

ID=39674574

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08751001.2T DK2109449T3 (da) 2007-02-01 2008-02-01 Lægemiddel til behandling af endometriose

Country Status (20)

Country Link
US (2) US8927568B2 (enExample)
EP (1) EP2109449B1 (enExample)
JP (1) JP5211073B2 (enExample)
AR (1) AR065139A1 (enExample)
AT (1) ATE516805T1 (enExample)
AU (1) AU2008211633B2 (enExample)
BR (1) BRPI0806944A2 (enExample)
CA (1) CA2676910C (enExample)
DK (1) DK2109449T3 (enExample)
IL (1) IL200032A (enExample)
JO (1) JO2730B1 (enExample)
MX (1) MX2009008191A (enExample)
NZ (1) NZ578569A (enExample)
PL (1) PL2109449T3 (enExample)
PT (1) PT2109449E (enExample)
RU (1) RU2423146C2 (enExample)
SA (1) SA08290041B1 (enExample)
SI (1) SI2109449T1 (enExample)
TW (1) TWI411436B (enExample)
WO (1) WO2008093247A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010150098A2 (en) * 2009-06-26 2010-12-29 Ferring International Center Sa Treatment of endometriosis
EP3017809A1 (en) 2014-11-07 2016-05-11 Ferring B.V. Drug-device unit containing quinagolide
WO2017210117A1 (en) * 2016-06-02 2017-12-07 Board Of Trustees, Southern Illinois University Treatment of endometriosis and niclosamide derivatives
JP6562332B2 (ja) * 2017-05-30 2019-08-21 有限会社イムノ 活性化ｔ細胞からのｉｌ−８産生を抑制するための組成物
RU2732251C1 (ru) * 2019-11-29 2020-09-14 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ лечения наружного генитального эндометриоза
US20240361338A1 (en) 2021-08-31 2024-10-31 Ferring B.V. Diagnosis and treatment of ectopic endometriosis
WO2024153752A1 (en) 2023-01-20 2024-07-25 Ferring B.V. Stereoselective synthesis of intermediates and synthesis of quinagolids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
WO1993003752A1 (en) * 1991-08-19 1993-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Decapeptide having dopamine stimulating activity
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US6127401A (en) * 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
RU2273481C2 (ru) * 2004-05-27 2006-04-10 Варвара Анатольевна Волкова Способ повышения эффективности лечения бесплодия, вызванного малыми формами внешнего генитального эндометриоза
WO2006117608A1 (en) * 2005-04-29 2006-11-09 Ferring International Center S.A. Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist
WO2010150098A2 (en) * 2009-06-26 2010-12-29 Ferring International Center Sa Treatment of endometriosis

Also Published As

Publication number Publication date
HK1134911A1 (en) 2010-05-20
IL200032A0 (en) 2010-04-15
SI2109449T1 (sl) 2011-11-30
WO2008093247A2 (en) 2008-08-07
RU2009129252A (ru) 2011-03-10
US20150073010A1 (en) 2015-03-12
RU2423146C2 (ru) 2011-07-10
AU2008211633B2 (en) 2011-04-21
US9023862B2 (en) 2015-05-05
SA08290041B1 (ar) 2012-06-05
IL200032A (en) 2015-06-30
EP2109449B1 (en) 2011-07-20
JP5211073B2 (ja) 2013-06-12
PL2109449T3 (pl) 2011-12-30
AR065139A1 (es) 2009-05-20
AU2008211633A1 (en) 2008-08-07
JO2730B1 (en) 2013-09-15
PT2109449E (pt) 2011-11-02
US8927568B2 (en) 2015-01-06
BRPI0806944A2 (pt) 2014-05-06
CA2676910A1 (en) 2008-08-07
WO2008093247A3 (en) 2008-12-04
TW200845989A (en) 2008-12-01
ATE516805T1 (de) 2011-08-15
US20100113499A1 (en) 2010-05-06
EP2109449A2 (en) 2009-10-21
MX2009008191A (es) 2009-08-12
NZ578569A (en) 2011-08-26
CA2676910C (en) 2012-01-03
JP2010517992A (ja) 2010-05-27
TWI411436B (zh) 2013-10-11

Similar Documents

Publication Publication Date Title
DK2240130T3 (da) Indretning til behandling af fedme
DK2173407T3 (da) Anordning til indgivelse af lægemiddel
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK3354276T3 (da) Sammensætninger til behandlingen af gastrointestinal inflammation
DK2154971T3 (da) Synergistisk farmaceutisk kombination til behandling af cancer
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2500047T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
DK2107917T3 (da) Injektionssted til injektion af lægemiddel
DK2478907T3 (da) Sammensætninger til behandling af kræft
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
BRPI0920521A2 (pt) combinação farmacêutica
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2182863T3 (da) Åbningsdilatator
DK2356093T3 (da) Carbazolforbindelser og terapeutiske anvendelser af forbindelserne
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
DK3005986T3 (da) Infusion af lægemidler
DK2010184T3 (da) Implatanter til behandlingen af dopamin associerede tilstande